LivaNova, a UK firm, won FDA approvals for its newest vagus nerve stimulation system for treating epilepsy in patients as young as four years old. The system, which includes the SenTiva implantable neurostimulator and the VNS Therapy Programming system, monitors brain activity and delivers therapy when it believes a seizure may be imminent. During (Read more...)